Modulation of Arachidonic Acid Release and Membrane Fluidity by Albumin in Vascular Smooth Muscle and Endothelial Cells
A lbumin is the major blood plasma protein that binds and transports various substances in the blood. Albumin is known to affect capillary permeability in vitro. 1, 2 Perfusion of vessels with protein-free solution dramatically increased hydraulic permeability in various vascular beds, [3] [4] [5] an effect that was prevented by adding serum albumin to the perfusate at concentrations as low as 1 mg ⅐ mL Ϫ1 6 or even 0.1 mg ⅐ mL
Ϫ1
. 7 Although several hypotheses have been proposed to explain the action of albumin on hydraulic permeability in microvessels, the exact mechanism(s) involved remain controversial. 1, 2 Conversely, arachidonic acid (AA) (2 to 5 mmol/L) has been demonstrated to increase permeability in cerebral microvessels and induced edema in rat brains. 8 Unterberg et al 9 found in 1987 that superfusion of cat brains with AA (0.03 to 0.3 mmol/L) opened the blood-brain barrier for Na ϩ -fluorescein and, at higher concentrations (3 mmol/L), for fluorescein isothiocyanate-dextran (molecular weight 62 000). The changes in the permeability of cultured cerebromicrovascular endothelial cells for trypan blue by AA (50 to 100 mol/L) did not depend on arachidonate metabolism, suggesting that events perturbing the cellular membrane may affect the permeability of cerebral capillaries. 10 Using a similar cell model, Villacara et al 11 in 1989 demonstrated that AA (100 mol/L) increased both the permeability of endothelial cells for trypan blue albumin and membrane fluidity in isolated endothelial cell membranes loaded with 1,6-diphenyl-1,3,5-hexatriene (DPH). The former effect was also mimicked by other fatty acids. 12 The correlation between the increased cell permeability and increased cell membrane fluidity has been demonstrated previously. 13, 14 Although the ability of albumin to bind long-chain polyunsaturated fatty acids with high affinity is well documented, 15 no data are available describing the interactions of albumin, AA, and membrane fluidity in vascular smooth muscle or endothelial cells.
We therefore have investigated whether BSA could affect the AA content in intact rat aorta, cultured smooth muscle, and endothelial cells, by measuring the release of radioactive AA and the steady-state fluorescence anisotropy as an indicator of the cell membrane fluidity. Some of the results have been presented in abstract form. 16, 17 
Materials and Methods
Experiments were performed on both freshly isolated rat aorta myocytes (fRAMs) and human mesenteric arterial myocytes (fHMAMs), cultured RAMs (cRAMs), and human umbilical vein endothelial cells (HUVECs). The procedure for obtaining human tissue was approved by the St Thomas's Hospital Ethical Committee.
Cell Isolation
Freshly isolated smooth muscle cells were prepared from either rat thoracic aorta (collected from 2 to 4 male Wistar rats, 200 to 300 g) or human mesenteric artery. Pieces of arteries (1 to 1.5 mm wide) were preincubated in nominally Ca 2ϩ -free physiological saline solution (Ca 2ϩ -free PSS) for 20 minutes at 36°C and then transferred into Ca 2ϩ -free PSS (5 mL) containing collagenase (3 mg ⅐ mL Ϫ1 ; 230 U/mg; Worthington), papain (1 mg ⅐ mL 
Cell Culture
HUVECs were isolated by collagenase perfusion (Type 1A, 1 mg ⅐ mL Ϫ1 ) for 25 minutes from umbilical cords obtained from full-term normal births. Dissociated cells were transferred to tissue culture flasks containing 12.5 mL of medium 199 supplemented with FCS (15% v/v), penicillin (100 IU ⅐ mL Ϫ1 ), streptomycin (100 g ⅐ mL Ϫ1 ), sodium heparin (90 IU ⅐ mL Ϫ1 ), and endothelial cell growth supplement (30 g ⅐ mL Ϫ1 ). RAMs were explant-cultured from freshly isolated aortas after removal of endothelium. Small pieces of tissue (Ϸ2 mm 2 ) were transferred to a 75-cm 2 tissue culture flask containing DMEM supplemented with FCS (10% vol/vol), penicillin (100 IU ⅐ mL Ϫ1 ), and streptomycin (100 g ⅐ mL
Ϫ1
). Cells were maintained in a humidified incubator at 37°C/5% CO 2 , and culture medium was replaced every 2 or 3 days until confluence was achieved. All cells were used before their fourth passage.
Isolated cell membranes were prepared from confluent HUVECs (passage 1, Ϸ3 to 4 ⅐ 10 6 cells). Cells were harvested using 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid solution (10 minutes at 37°C), resuspended in 2 mL PSS, and homogenized using the Ultra-Turrax T25 homogenizer (Janke & Kunkel, IKALabortechnik) at 24 000 rpm for 2 minutes at 4°C. Cell debris and nuclei were removed by centrifugation at 1000g for 10 minutes at 4°C. The supernatant (predominantly plasmalemmal/sarcolemmal membranes) was diluted to 6 mL with PSS and used for measurement of fluorescent anisotropy as described below. All media, PBS, and FCS were purchased from Gibco BRL (Paisley, UK). All other chemicals and reagents were purchased from either Sigma Chemical or BDH Merck.
Measurement of [ 3 H]AA Release

Intact Rat Aorta
Twelve rat aorta rings (1 to 1.5 mm long) were placed in 1 mL of PSS and incubated with 2.5 Ci [ 3 H]AA (223.4 Ci/mmol, NEN) at a final concentration of 11.2 nmol/L and cold AA (5 mol/L) for 24 hours at ϩ4°C. Two rings were transferred into each superfusion chamber (200 L), retained between 2 filter paper discs, and superfused with PSS at a flow rate of 0.7 mL ⅐ min Ϫ1 at room temperature using a Brandel Superfusion System. Tissue was washed for 20 minutes, and then 2 minutes (1.4 mL) fractions were collected. At the end of each experiment, the aorta rings and filter papers were removed and dissolved in 0.5 mL of Soluene 350 and then were neutralized with glacial acetic acid (200 L). The radioactivity was measured as disintegrations per minute after the addition of scintillant (3 mL; Ultima Gold) using a Wallac 1409 liquid scintillation counter. The results are presented as a percentage of fractional release (% FR) of [ 3 H]AA.
Cultured RAMs
Confluent cRAMs (passage 1) were fed with 0. 
Measurement of Cell Membrane Fluidity
Cell membrane fluidity was measured using the fluorescence probe DPH (Sigma). DPH was dissolved in tetrahydrofuran to obtain a stock solution of 4 mmol/L. Cell suspension (4 to 8 ⅐ 10 5 per mL in 3 mL) was incubated in the presence of 2 mol/L DPH for 30 minutes at 35°C with constant stirring. The penetration of DPH into the cell membrane was monitored by measuring the increasing fluorescence, which reached a steady-state level within 20 to 25 minutes of loading. Cells then were concentrated by centrifugation at 1100g and resuspended in a final volume of fresh PSS to give 2 to 3ϫ10 5 cells per mL. Substances tested were added cumulatively to the cuvette containing 2 mL of cell suspension. Because the maximal changes in the total volume of the solution were Ͻ10% no correction of concentration was made.
Steady-state fluorescent polarization of DPH was measured using a Perkin-Elmer SP-50 spectrophotometer at 35°C. DPH was excited by vertically polarized light at 360 nm, and its emission intensities were detected at 430 nm through a polarizer orientated parallel and perpendicular to the direction of polarization of the excitation beam. Calculation of the steady-state fluorescence anisotropy (r) was performed using Perkin-Elmer computer software according to the equation:
G is a correction factor for a light scattering measured by exciting the sample with horizontally polarized light and measuring the parallel and perpendicular components. G was determined routinely before each experiment using Perkin-Elmer computer software.
Modification of Albumin
Fatty acid-free (fraction V) BSA was modified using a procedure described in detail elsewhere. 18 Briefly, a solution of 0.825 g BSA in 25 mL of 0.2 mol/L NaOH was mixed with 330 mg 1,2-cyclohexanedione for 5 minutes and then titrated with HCl to neutral pH. The solution was dialyzed at 4°C for 48 to 72 hours. The degree of modification of the arginine residues was Ͼ90% 18 and was not determined here. Breakdown of BSA after the modification process was assessed by SDS-PAGE analysis and was not significant. The final concentration of protein was estimated using the standard Bradford protein assay (Sigma). BSA concentration (mol/L) was calculated assuming a relative molecular mass of 66 000.
Data are presented as meanϮSEM and compared for significance using the 2-tailed Student t test; differences were deemed significant at PϽ0.05 unless stated otherwise. Data analysis was performed using Origin 4.1 (Microcal Software Inc).
Results
Release of [ 3 H]AA and its Modulation by BSA in Intact Rat Aorta
Initial background [
3 H]AA release measured in the absence of drug was between 0.2% and 1.7% FR (mean, 0.4Ϯ0.04; nϭ54), which typically decreased gradually by 20% to 30% toward the end of the experiment ( Figure 1A , E). This decrease apparently was not due to the slow removal of bound radioactive label from the extracellular space, because perfusion of aortic rings with a high concentration of "cold" AA (50 mol/L) did not affect Figure 1A , F). To estimate the results quantitatively, the maximal FR in the presence of ionomycin was corrected for the average background signal measured immediately before drug application and at the end of experiment ( Figure 1 ) and is presented in Table 1 . Statistical analysis showed a significant increase in [ 3 H]AA release in comparison to the control data measured in a similar manner.
Addition of BSA (1 mg ⅐ mL
Ϫ1
) to the perfusate for 8 minutes caused a dramatic initial rise in release of [ 3 H]AA within the first 2 minutes, followed by a slow decrease ( Figure 2A ). After removal of BSA, the signal returned to the basal level within 6 to 8 minutes. Two subsequent applications of the same concentration of BSA initiated smaller and similar steady-state increases in the release of radioactive label ( Figure 2A ). To compare these data quantitatively, the area under the curve in the presence of protein (net [ 3 H]AA FR) corrected for the background FR was calculated during each application. Figure 2B shows the mean data obtained in 9 to 14 similar experiments. The net [
3 H]AA FR in response to the second and third applications of BSA (57% and 68% decreases, respectively) fell significantly in comparison to that during the first addition; however, there were no significant differences between the last 2 applications.
Analogous experiments performed on cRAMs (passage 1) after prolonged incubation with radiolabeled AA at 37°C (see Materials and Methods), when the label would be expected to equilibrate within various intracellular phospholipid pools more completely than in intact tissue, showed similar results ( Figure 2C and 2D ). Initial application of BSA (1 mg ⅐ mL Ϫ1 ) caused a large increase in [ 3 H]AA release ( Figure 2C ), which decayed in a similar manner to that observed in intact tissue. Two subsequent additions of BSA (applied in 14-minute intervals) resulted in virtually identical responses ( Figure  2C ), in contrast to the intact tissue preparations (Figure 2A ). However, after subsequent incubation of cRAMs without stimulation for 70 minutes, the fourth application of the same concentration of BSA strongly increased [ 3 H]AA release ( Figure 2C ). The net [ 3 H]AA FR in response to the fourth application of BSA was significantly larger (PϽ0.02 and PϽ0.03; paired t test) than that recorded during the previous third and second applications of the protein, respectively ( Figure 2D ).
The effect of a longer (20 minutes) application of BSA (1 mg ⅐ mL
) was studied in intact rat aorta using the experimental protocol described above for ionomycin. Under these conditions, the [ 3 H]AA FR remained elevated over the entire albumin application period, although it had decreased by 66Ϯ2% (nϭ6) at the end of the application of BSA, approaching a steady-state level ( Figure 3A) . Peak responses to this concentration of BSA in these experiments and experiments described in Figure 2A (only the first application was used) were corrected for the background release as described above and averaged and are presented in Table 1 
BSA (not shown).
␥-Globulin, the second most abundant plasma protein, could not stimulate significantly [ 3 H]AA release under similar conditions at a concentration of 1 mg ⅐ mL Ϫ1 ( Figure 3B ). Myoglobin (1 mg ⅐ mL
Ϫ1
) was also ineffective ( Table 1) . Figure 4A shows that the application of BSA (15 mol/L; Ϸ1 mg ⅐ mL
Modulation of Cell Membrane Fluidity by BSA
Ϫ1
) caused a large increase in steady-state fluorescence anisotropy (decrease in cell membrane fluidity) in cRAMs (passage 2) preloaded with DPH, as described in Materials and Methods. This effect was reversible and could be obtained repeatedly after washing cells with fresh PSS. The addition of BSA did not affect cell viability (assessed by trypan blue exclusion), although 16% to 20% of cells were lost during repeated washing and centrifugation procedures ( Figure 4A ). Cumulative addition of BSA to a cuvette containing HUVECs (passage 2) caused a progressive steplike increase in r. The effect of BSA become noticeable at BSA concentrations near 0.5 mol/L, and r reached a maximal value of Ϸ0.29 to 0.3 when the concentration of protein exceeded 10 mol/L (Figure 4B, F) . Under control conditions, however, no change in anisotropy occurred, and a small decrease in r usually was observed ( Figure 4B, E) . To compare the effect of BSA on the steady-state anisotropy in various cell types, r was calculated as the mean value when the effect stabilized at each protein concentration and is plotted against BSA concentration in Figure 4C . This dependence was sigmoidal and was fitted to the following equation: Table 2 . Significant differences in the relative potency of BSA in increasing the membrane fluidity neither between different cultured and freshly isolated cell types nor between different passages (K 1/2 , 0.1 and 6 mol/L or 0.007 and 0.4 mg ⅐ mL Ϫ1 , respectively) within the same cell type were found. In 2 experiments with fHMAMs, qualitatively similar results were obtained, with K 1/2 ϭ10 and 7.8 mol/L and r max and r min ϭ0.3 and 0.31, and 0.18 and 0.24, respectively.
Qualitatively similar results of the effect of BSA on membrane fluidity also were obtained on isolated plasmalemmal/sarcolemmal membranes prepared from HUVECs. K 1/2 was 9.6Ϯ3.9 mol/L, and r max and r min were 0.31Ϯ0.02 and 0.2Ϯ0.003, respectively, in 3 preparations tested.
␥-Globulin exerted no significant effect on r over a similar range of concentrations in HUVECs (passage 1) ( Figure 4D , E) and other cell types (Table 2) . Myoglobin also was ineffective up to a concentration of 100 mol/L (molecular mass, 17 500; Table 2 ).
Effect of AA on Cell Membrane Fluidity
Cumulative addition of various doses of AA to the suspension of fRAMs produced the opposite effect on r to that seen on addition of BSA, decreasing its value ( Figure 5A, F) . Changes in r caused by AA also had a sigmoidal dependency on the log of the concentration, and data were analyzed using the same equation described in the legend of Figure 4C ( Figure 5B ). No significant differences in K 1/2 for AA were found between fRAMs, cRAMs, and HUVECs (Table 2) , although large variations in K 1/2 values (5 to 129 mol/L) were observed. The AA solvent DMSO did not affect cell membrane fluidity ( Figure 5A and 5B, E).
The interaction of BSA and AA in their capacity to modulate cell membrane fluidity was studied by applying mixtures of these substances to fRAMs. Figure 5C illustrates the results of such an experiment. Cells were split into 3 cuvettes, and BSA (10 mol/L) and AA (100 mol/L) were added to 2 cuvettes. As expected, the addition of these substances caused contrasting changes in r that quickly reached steady-state levels of Ϸ0.3 and 0.1 for BSA (E) and AA (F), respectively. Mixtures of BSA (10 mol/L) and various concentrations of AA were introduced to the third cuvette ( Figure 5C , ‚). When 10 mol/L BSA and 100 mol/L AA (1:10 ratio) were added to the suspension of fRAMs, r increased, but only by Ϸ50% compared with when the same concentration of BSA alone was added. An increase in the BSA:AA molar ratio to 1:20 because of further addition of AA caused a greater decrease in r, and only at a concentration of AA 40 times greater than that of BSA (400 mol/L) did r reach the level measured in the presence of 100 mol/L AA alone ( Figure 5C ). Qualitatively similar results were obtained in another experiment.
Comparison of the Effect of Native and Modified BSA on Cell Membrane Fluidity and [
H]AA Release
It has been proposed previously that positively charged arginine residues in the albumin molecule are at or near binding sites for long-chain fatty acids. 19 To disrupt these putative binding sites in the BSA molecule, the protein was modified on arginine residues (see Materials and Methods). Figure 6A and 6B illustrates the comparison of the effect of native (E) and modified (F) BSAs on r in cRAMs (passage 1). Figure 6 shows that modified BSA was Ϸ100 times less potent than the native protein in its ability to decrease cell membrane fluidity ( Figure 6A and 6B) . In general, modified BSA was significantly less potent (K 1/2 , 10 to 63 mol/L) than native protein in all cell types studied ( Table 2) .
A comparison of the effect of native and modified BSA (0.2 mg ⅐ mL Ϫ1 ) on [ 3 H]AA release showed that modified BSA did not mimic the effect of the native protein in increasing the release of AA in intact rat aorta preparations ( Figure 6C ). Increasing the concentration of modified BSA up to 1 mg ⅐ mL Ϫ1 also did not potentiate [ 3 H]AA release significantly (Table 1) .
Discussion
The major findings described in the present study are: (1) BSA was able to increase release of AA from both intact rat aorta and cultured smooth muscle cells; (2) BSA increased steady-state anisotropy (decreased cell membrane fluidity) in DPH-labeled vascular smooth muscle and endothelial cells; (3) both effects were not mimicked by other plasma proteins such as ␥-globulin and myoglobin; (4) AA caused the opposite effect of that of BSA, increasing cell membrane fluidity; and (5) the effect of BSA on both cell membrane fluidity and AA release was significantly decreased when the protein was modified at its arginine residues.
Effect of BSA on AA Release
To the best of our knowledge, the release of labeled AA from intact blood vessels has not been demonstrated previously. To confirm whether labeled AA is incorporated into some intracellular phospholipid pools, we examined the effect of ionomycin, which has been shown to enhance the activity of phospholipase A 2 by elevating the intracellular Ca 2ϩ concentration. 20 Under our conditions, ionomycin caused a significant and sustained [ 3 H]AA release. This suggests that the radioactive label was incorporated at least into a phospholipase A 2 -accessible phospholipid pool.
We found that BSA significantly stimulated AA release in a concentration-dependent manner in rat aortic rings ( Figures  2A, 2B , and 3A). This effect was not due to removal of extracellular bound radioactive AA by BSA, because first, perfusion of tissue with a high concentration (50 mol/L) of "cold" AA, which would be expected to displace extracellular bound radioactive AA, did not cause significant changes in mL Ϫ1 BSA resulted in sustained AA release in intact tissue. A similar effect also was observed during a continuous perfusion of tissue with a 5-fold lower concentration of BSA ( Figure 6C, E) . In addition, we were able to obtain similar multiple responses to BSA in cultured RAMs ( Figure 2C and 2D) under conditions in which the label presumably was distributed more equally within intracellular phospholipid pools. 21 The small background release of [ 3 H]AA and the initial rapid release in response to BSA followed by a sustained release in the presence of protein are consistent with the possibility that there is a small pool of a BSA-accessible endogenous [ 3 H]AA. Because it seems unlikely that BSA readily would cross the membrane because of its large molecular mass and lipid insolubility, it is probable that the protein can interact with the extracellular surface of both endothelial and smooth muscle cells, thus removing AA from the membrane. Although BSA is able to bind other phospholipids, such as phosphatidylcholine and lysophosphatidylcholine, which also could contain labeled AA, this seems to be an unlikely explanation for our results, because it has been shown that the release of lysophosphatidylcholine by BSA only occurred after a lag phase of 30 minutes and then increased slowly over 4 hours in cultured rat hepatocytes. 22 Additionally, BSA-induced release of phosphatidylcholine was found to be very small and slow in the same cells. 22 Additionally, the data shown in Figure 2C and 2D indicate that the fraction of BSA-accessible [ 3 H]AA recovered completely after 70 minutes in cultured RAMs. These results could suggest that there is a turnover of AA in vascular smooth muscle and endothelial cells, yielding free AA that was then released from intact tissue or isolated cells by BSA.
Modulation of Cell Membrane Fluidity by BSA and AA
To evaluate the possibility that BSA could affect the physical properties of the cell membrane, the effect of BSA, as well as that of ␥-globulin, myoglobin, and AA (cell membrane fluidity measured by DPH fluorescence anisotropy) was compared in endothelial and smooth muscle cells. DPH is the most frequently and successfully used fluorescence probe in lipid bilayers, isolated membranes, and living cells. 23 The main disadvantages of using living cells in measurements of fluorescence polarization or anisotropy are heterogeneity of the intact cell membrane and slow passive diffusion of DPH into intracellular membrane structures. 23 Both factors make a quantitative interpretation of the results difficult. Partition of DPH could be estimated by monitoring the degree of fluorescence polarization, 24 which would be expected to decrease with time during loading of DPH. 23 Under our experimental conditions, no changes in the fluorescence anisotropy were found during a 30-minute loading procedure (not shown). In addition, the reversibility of the effect of BSA ( Figure 4A ) also suggests that the phenomenon was associated preferentially with the extracellular cell membrane.
BSA (1 mg ⅐ mL
Ϫ1
) caused a marked and reversible increase in r ( Figure 4A ). The effect on r appeared at concentrations of BSA between 0.007 and 0.04 mg ⅐ mL
(0.1 to 0.5 mol/L), and r was saturated at concentrations Ͼ0.7 mg ⅐ mL Ϫ1 (10 mol/L; Figure 4B and 4C). This effect appeared to be specific to BSA, because it was not mimicked by ␥-globulin or myoglobin. The potency of the effect of BSA was similar in freshly isolated smooth muscle and cultured smooth muscle and endothelial cells (Table 2 ). An equivalent effect of BSA was also recorded with isolated HUVEC membrane preparations. Our preliminary results also indicated that BSA caused a qualitatively similar effect in the DPH-loaded 3T3 fibroblast cell line (K 1/2 ϭ1.2Ϯ0.4 mol/L; nϭ3). These results suggest that the effect of BSA on the dynamic properties of the cell membrane is not limited to a particular cell type and may be a general phenomenon.
The effect of BSA on the fluorescence anisotropy was antagonized by AA, which caused the opposite effect on cell membrane fluidity ( Figure 5 ). The apparent potency of the effect of AA on cell membrane fluidity was significantly lower than that of BSA (PϽ0.02 to 0.008) in all cell types studied ( Table 2) . It is well known that serum albumin possesses multiple high-affinity binding sites for fatty acids 25 ; it is able to bind Ն20 M of fatty acids per mole protein. 26 These facts concur with our findings, which showed that the effect of BSA on r could be completely reversed only at AA concentrations 40 times greater than that of the protein. This suggests that BSA alters the cell membrane fluidity because of its high-affinity binding of AA and after the "extraction" of the fatty acid from the cell membrane. Our other experimental observations also support this idea. First, the experiments with BSA modified on arginine residues that were proposed to be associated with the putative fatty acid binding sites 19 showed that the modified protein was significantly less potent in modulation of the cell membrane fluidity and did not stimulate release of AA from intact tissue at concentrations between 0.2 and 1 mg ⅐ mL Ϫ1 ( Figure 6 ; Tables 1 and 2 ). Also, the presence of bilirubin (1 mol/L), which has a higher affinity for albumin than AA but binds to a different binding site in the protein molecule, 26 did not prevent the increase in r by BSA (1 mol/L; data not shown).
What Is the Physiological Significance of the Effects of BSA?
Previous reports indicate that albumin alters several processes in both intact vasculature and single cells. The mechanisms underlying its actions remain incompletely understood. A widely studied observation is the effect of albumin on capillary permeability, 1,2 which it dramatically decreases if the vessel first has been superfused with protein-free solution. The characteristic features of this effect of albumin on capillary permeability were: (1) it occurred at concentrations of Յ1 mg ⅐ mL Ϫ1 7,27 ; (2) it was not reproduced by myoglobin and hemoglobin in similar concentration ranges 28 ; and (3) BSA, modified in a manner similar to that employed in the present article, did not affect the capillary permeability. 18 Taking into account reports that showed the opposite effect of AA on capillary permeability, 9 -11 there is a positive correlation between the effect of BSA and AA on the membrane fluidity demonstrated in the present article and corresponding capillary permeability changes. This suggests that the modulation of capillary permeability by albumin could be mediated, at least partly, via the affect of protein on the cell membrane fluidity. This is also supported by the direct correlation between membrane fluidity and membrane permeability to water and small solutes, which previously has been demonstrated in artificial membrane vesicles, 29 bovine tracheal epithelial cell apical membranes, 13 and microvillus membrane vesicles prepared from rat small intestine. 14 The contribution of the cell membrane fluidity to the transport of macromolecules across the capillary is less understood, and the binding of albumin to the glycocalyx is thought to play an important role in this process.
1,2 Specific albumin-binding proteins of both low (18 and 31 kDa) 30 and high (60 kDa) 31 molecular weight have been identified in endothelial cells, which could play the role of the anchor protein for albumin on the surface of the cell membrane. The possibility that an alteration in membrane fluidity could affect the structure of the extracellular glycocalyx matrix cannot be excluded entirely, and further experimental work is required to clarify such a possibility.
In 33 It was suggested by these workers that albumin might modulate capillary permeability by the removal of active lipids that raise [Ca 2ϩ ] i levels. 33 One possible candidate for the putative lipid is thought to be lysophosphatidic acid 35 ; however, in 1995, Nadal et al 34 suggested that it also could be a different lipid. Free AA is known to increase [Ca 2ϩ ] i directly in various cell types. 36, 37 AA also activates the Ca 2ϩ -activated K ϩ current. 38, 39 In endothelial cells, this will lead to hyperpolarization of the cell membrane and stimulation of Ca 2ϩ influx because of an increased electrochemical gradient for Ca 2ϩ . 40 An increase in membrane fluidity by AA could also affect the Ca 2ϩ leak through the endothelial cell membrane, which was shown to be important in the regulation of Ca 2ϩ homeostasis in these cells. 41 Therefore, the decrease in [Ca 2ϩ ] i by albumin in part might be due to a reduction of the concentration of membrane AA by the protein. Our preliminary data also showed that lysophosphatidylcholine potently increased the cell membrane fluidity in vascular and endothelial cells, 16 which may suggest that lysophospholipids can share a mechanism similar to the mechanism we described for AA, although this requires further investigation.
